FDA Approved: SAMSCA — Supplemental Application (Otsuka America Pharmaceutical, Inc.)

View source ↗

Summary

FDA approved a supplemental application for SAMSCA (tolvaptan) submitted by Otsuka America Pharmaceutical, resulting in updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• Samsca (tolvaptan)

Snippet

SUPPL AP for SAMSCA (TOLVAPTAN)